
Faricimab Intravitreal Injection in Korea
Treatment Overview Faricimab Intravitreal Injection is an advanced dual-action anti-VEGF and anti-Angiopoietin-2 (Ang-2) therapy for managing wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME),









